You are here

Article Text

Article menu
Download PDFPDF
Letter to the editor
Colorectal cancer screening: surely FIT for us too
  1. Ethna McFerran,
  2. Frank Kee,
  3. Helen G Coleman
  1. Centre for Public Health, Queen’s University Belfast Centre for Public Health, Belfast, UK
  1. Correspondence to Dr Ethna McFerran, Queen’s University Belfast Centre for Public Health, Queens University Belfast, Belfast BT7 1NN, UK; e.mcferran{at}qub.ac.uk

https://doi.org/10.1136/flgastro-2018-101125

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    A dwindling minority of countries now offer guaiac-based colorectal cancer (CRC) screening tests (including Croatia, Finland, Greece and Hungary) since, for over a decade, faecal immunochemical testing (FIT) has been shown to be more effective.1 FIT detects more positive results compared with guaiac-based tests with fewer false negatives and for participants is a more acceptable test.

    In Northern Ireland, 3 years on from when the UK National Screening Committee (UKNSC) recommended a move to FIT (in January 2016), no decision to support its implementation has been approved. The inequity is unacceptable, as UKNSC published economic evidence showing FIT implementation would improve outcomes with cost savings.2

    Transition to FIT in England and Wales continues with additional plans …

    View Full Text